Scholarlink

This chapter reviews current recommendations from the 2023 American College of Cardiology (ACC)/American Heart Association (AHA)/American College of Clinical Pharmacy (ACCP)/Heart Rhythm Society (HRS) and 2020 European Society of Cardiology (ESC) on the diagnosis and management of atrial fibrillation. Anticoagulation for stroke prevention in atrial fibrillation (AF) or atrial flutter AF/flutter ≥ 48 h (>24 h per 2020 ESC [3]) or unknown duration undergoing cardioversion [1]:

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Anticoagulation for Atrial Fibrillation or Atrial Flutter

  • 章节

  • 发表日期：

    2025年

查看全文
  • Jennifer Pai Lee

摘要

This chapter reviews current recommendations from the 2023 American College of Cardiology (ACC)/American Heart Association (AHA)/American College of Clinical Pharmacy (ACCP)/Heart Rhythm Society (HRS) and 2020 European Society of Cardiology (ESC) on the diagnosis and management of atrial fibrillation. Anticoagulation for stroke prevention in atrial fibrillation (AF) or atrial flutter AF/flutter ≥ 48 h (>24 h per 2020 ESC [3]) or unknown duration undergoing cardioversion [1]: